SEC FORM 4
$98,465.88
Mineralys Therapeutics, Inc. (MLYS)
Acquisition (code M) of 7,437 shares at $13.24 per share.
Reporting Person Warren Eric · Officer Title Chief Commercial Officer · Transaction Code M
Traded Aug 21, 2026 · Disclosed Aug 25, 2026
Source: SEC Form 4 · 0001916048-26-000012 · filed 2026-08-25 · View filing →